7-day roundup
The 10 most notable cure or vaccine studies from the last week.
A study testing a new mRNA vaccine to prevent chlamydia infection in adults aged 18-29. It's currently recruiting 1,560 participants.
Read lead report →Study testing if an extra dose of the shingles vaccine improves protection for kidney transplant patients. Enrolling 132 participants.
Read report →A Phase 1 study testing new vaccine formulations for RSV and H5N1 bird flu in healthy adults. It measures safety and immune response.
Read report →A study testing a new COVID-19 booster vaccine made from a modified animal virus in healthy adults to check its safety and immune response.
Read report →Phase 1 study testing safety of a new RSV vaccine in healthy women aged 18-49. Looking at immune response and side effects.
Read report →